Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: An orally effective analog of bretylium for suppression of ventricular tachyarrhythmias
- 31 October 1982
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 50 (4) , 728-734
- https://doi.org/10.1016/0002-9149(82)91226-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orallyThe American Journal of Cardiology, 1982
- Toward preventing coronary death from ventricular fibrillation.Circulation, 1976
- Epidemiology of Sudden DeathArchives of internal medicine (1960), 1972
- Disposition of bretylium in man and rat; A sensitive chemical method for its estimation in plasma and urineClinical Pharmacology & Therapeutics, 1970
- Antiarrhythmic drugs in the prevention of ventricular arrhythmias related to paired pacingThe American Journal of Cardiology, 1970
- Thiazide-Induced Hypokalemia With Associated Major Ventricular ArrhythmiasPublished by American Medical Association (AMA) ,1968
- Bretylium Tosylate for Suppression of Ventricular Fibrillation after Experimental Myocardial InfarctionNature, 1968
- Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylateThe American Journal of Cardiology, 1968
- Quantitative comparison of bretylium with other antifibrillatory drugsThe American Journal of Cardiology, 1968
- Bretylium tosylate for suppression of induced ventricular fibrillationThe American Journal of Cardiology, 1966